Sillito F, Rampotas A, Cheok K, Pomplun S, Baker R, Marafioti T, O’Reilly M, Gupta R, Kirkwood AA, Roddie C. Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy. haematol [Internet]. 2025Nov.1 [cited 2025Dec.5];110(11):2812-8. Available from: https://haematologica.org/article/view/12049